T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDS
201
DELISTED
HD Supply Holdings, Inc.
HDS
| $687M | 0.11% |
16,024,469
+163,457
| +1% | +$6.62M |
|
202
Verisk Analytics
VRSK
$23.6B
| $686M | 0.1% |
6,377,135
-125,368
| -2% | -$13.3M |
|
|
CTLT
203
DELISTED
CATALENT, INC.
CTLT
| $686M | 0.1% |
16,366,611
+309,312
| +2% | +$12.5M |
|
204
Sherwin-Williams
SHW
$88.5B
| $683M | 0.1% |
5,026,440
+726,057
| +17% | +$93.9M |
|
205
Wabtec
WAB
$50.3B
| $681M | 0.1% |
6,906,811
+1,207,596
| +21% | +$112M |
|
206
GSK
GSK
$102B
| $672M | 0.1% |
13,341,466
+172,419
| +1% | +$8.68M |
|
207
Accenture
ACN
$110B
| $669M | 0.1% |
4,092,345
+91,479
| +2% | +$14.2M |
|
208
Allegion
ALLE
$14.3B
| $669M | 0.1% |
8,641,636
+2,482,078
| +40% | +$199M |
|
209
Atmos Energy
ATO
$28.6B
| $665M | 0.1% |
7,382,475
-290,740
| -4% | -$25.2M |
|
210
Entergy
ETR
$49.7B
| $659M | 0.1% |
16,302,392
+6,990,042
| +75% | +$277M |
|
211
EQT Corp
EQT
$34B
| $658M | 0.1% |
21,915,823
+1,289,127
| +6% | +$36M |
|
212
Charter Communications
CHTR
$18.8B
| $658M | 0.1% |
2,243,403
+971,234
| +76% | +$279M |
|
213
Bank of America
BAC
$448B
| $638M | 0.1% |
22,649,229
-16,706,081
| -42% | -$498M |
|
|
CLGX
214
DELISTED
Corelogic, Inc.
CLGX
| $635M | 0.1% |
12,242,034
+635,512
| +5% | +$31.9M |
|
215
United Airlines
UAL
$41B
| $601M | 0.09% |
8,614,245
+430,403
| +5% | +$29.9M |
|
216
S&P Global
SPGI
$120B
| $599M | 0.09% |
2,938,864
-105,526
| -3% | -$20.8M |
|
217
Rayonier
RYN
$6.45B
| $598M | 0.09% |
17,041,632
-6,739,952
| -28% | -$231M |
|
218
Canadian Natural Resources
CNQ
$98.1B
| $598M | 0.09% |
33,854,976
+983,007
| +3% | +$16.6M |
|
219
Phillips 66
PSX
$89.5B
| $596M | 0.09% |
5,304,402
+4,587,253
| +640% | +$516M |
|
220
Sarepta Therapeutics
SRPT
$1.92B
| $594M | 0.09% |
4,495,963
+1,097,796
| +32% | +$104M |
|
221
Webster Financial
WBS
$12.8B
| $590M | 0.09% |
9,254,663
-205,841
| -2% | -$12.8M |
|
222
Franklin Resources
BEN
$16.9B
| $588M | 0.09% |
18,335,331
+10,350,694
| +130% | +$347M |
|
223
Bristol-Myers Squibb
BMY
$130B
| $587M | 0.09% |
10,609,357
-258,159
| -2% | -$13.9M |
|
224
Neurocrine Biosciences
NBIX
$16.5B
| $583M | 0.09% |
5,930,307
-334,357
| -5% | -$29.9M |
|
225
Biogen
BIIB
$30.1B
| $573M | 0.09% |
1,973,631
-2,048,468
| -51% | -$576M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.